Roche confirms US government agreement to purchase additional doses of Regeneron’s casirivimab and imdevimab

by NASDAQ Market News January 12, 2021

NASDAQ Market News
Click here to email author

Cullinan Management Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Predictive Oncology Announces Closing of $3.074 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Ads